IP Library Granted Patent US 11,529,420
Granted Patent B2
US 11,529,420 · App. 16/935,110 · Granted Dec 20, 2022

Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same

Inventors: Michael Sekar (Palo Alto, CA); Felix Theeuwes (Los Altos Hills, CA); Keith Edward Branham (Pelham, AL); John W Gibson (Springville, AL); James Matriano (Mountain View, CA); Whitney Moro (Birmingham, AL); John Tipton (Leeds, AL); William Van Osdol (Mountain View, CA); Su Il Yum (Los Altos, CA)
Assignee: DURECT CORPORATION
A61K47/54A61K9/0019A61K9/1647A61K9/19A61K31/352A61K31/706A61K31/785A61K38/26A61K38/27A61K38/28A61K38/31A61K39/39516A61K47/593
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,529,420
App. No.
16/935,110
Granted
Dec 20, 2022
Kind
B2
Abstract

The present disclosure generally provides complexes including a pharmaceutically active agent and a functionalized polymer, wherein the functionalized polymer includes repeat units, the repeat units including ionizable repeat units having at least one ionizable side group and/or ionizable end group, a plurality of the at least one ionizable groups forming non-covalent bonds with the pharmaceutically active agent. Polymers which may be used to form such complexes as well as methods of making and using the complexes and related compositions are also provided.

Claims (13)

1. A method comprising:

providing a precursor polymer comprising repeat units, the repeat units comprising functionalizable repeat units comprising at least one functionalizable side group;

obtaining a functionalized polymer by transforming, using click chemistry, said functionalizable repeat units into ionizable repeat units comprising at least one ionizable side group; and

combining the functionalized polymer with a pharmaceutically active agent to form a complex in which a plurality of the at least one ionizable side group forms a plurality of non-covalent bonds with the pharmaceutically active agent.

2. The method of claim 1 , wherein said transforming, using click chemistry, comprises effecting a cycloaddition reaction.

3. The method of claim 2 , wherein said cycloaddition reaction is a Diels-Alder cycloaddition reaction.

4. The method of claim 2 , wherein said cycloaddition reaction is a Huisgen 1,3-dipolar cycloaddition reaction.

5. The method of claim 2 , wherein said cycloaddition reaction is a cycloaddition reaction between an azide and an alkyne to form a linkage comprising a 1,2,3-triazole.

6. The method of claim 1 , wherein the at least one functionalizable side group is an azido group and wherein the transforming, using click chemistry, comprises reacting the precursor polymer with an alkyne to form the functionalized polymer, the functionalized polymer comprising at least one 1,2,3-triazole ring.

7. The method of claim 1 , wherein the at least one functionalizable side group is a leaving group and wherein the transforming, using click chemistry, comprises: (a) transforming the leaving group into an azido group and thereby providing a polymer intermediate; and (b) reacting the polymer intermediate with an alkyne to form the functionalized polymer, the functionalized polymer comprising at least one 1,2,3-triazole ring.

8. The method of claim 1 , wherein the at least one functionalizable side group is an alkynyl group and wherein the transforming, using click chemistry, comprises reacting the precursor polymer with an azide to form the functionalized polymer, the functionalized polymer comprising at least one 1,2,3-triazole ring.

9. The method of claim 1 , wherein the transforming, using click chemistry, comprises a monovalent copper catalyzed reaction or a ruthenium catalyzed reaction.

10. The method of claim 1 , wherein the transforming, using click chemistry, comprises a copper catalyzed azide-alkyne cycloaddition reaction.

Assignments (4)
SECURITY INTEREST Recorded Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 074223/0753 →
SECURITY INTEREST Recorded Mar 30, 2026
From: MEDICIS PHARMACEUTICAL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0509 →
MERGER Recorded Feb 25, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073889/0196 →
MERGER Recorded Feb 19, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073837/0231 →